9.7 Industrial Applications of the Jacobsen Hydrolytic Kinetic Resolution Technology

Comprehensive Chirality

Volumn 9, Issue , 2012, Pages 129-146

  Larrow, J F ^a   Quigley, P F ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b Shasun Pharma Solutions Ltd   (United Kingdom)

Author keywords

1,2 diols; Asymmetric catalysis; Chiral (salen) metal catalysts; Chiral building blocks; Cooperative catalysis; Epoxides; Hydrolytic kinetic resolution; Industrial processes; Oligomeric catalysts

Indexed keywords

EID: 84902416890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-095167-6.00910-1     Document Type: Chapter

References (65)

1. Kagan H.B., Fiaud J.C. Kinetic Resolution. Topics in Stereochemistry 1987, Vol. 14. For the leading reference on kinetic resolutions, see: (a), Wiley, New York, pp 249-330. See also the discussion in reference 4.
2. For reviews of chiral (salen)-metal complexes and the reactions catalyzed by them, see: (a) Larrow, J. F.; Jacobsen, E. N. Asymmetric Processes Catalyzed by Chiral (Salen)Metal Complexes. In Topics in Organometallic Chemistry; Larsen, R. D., Ed.; Springer-Verlag: Berlin, 2004, Vol. 6; pp 123-152.
3. Cozzi P.G. Chem. Soc. Rev. 2004, 33:410-421.
4. Decortes, A.; Castilla, A. M.; Kleij, A. W. Angew. Chem. Int. Ed. 2010, 49(51), 9822-9837.
5. Federsel, H.-J. Asymmetry in the Plant: Concepts and Principles for the Scale-Up of Asymmetric Organic Reactions. In Comprehensive Chirality; Hughes, D. L., Ed.; Elsevier: London, 2012, Vol. 9; Chapter 9.2.
6. Asymmetric Catalysis on Industrial Scale 2004, Wiley-VCH, Weinheim. H.-U. Blaser, E. Schmidt (Eds.).
7. Keith J.M., Larrow J.F., Jacobsen E.N. Adv. Synth. Catal. 2001, 343(1):5-26.
8. Kumar K., Naidu V., Gupta P. Tetrahedron 2007, 63(13):2745-2785.
9. Quigley P.F. Chim. Oggi 2009, 27(6):26-29.
10. Kumar P., Gupta P. Synlett 2009, 9:1367-1382.
11. DiMare, M. Innovations Pharmaceut. Technol. 2002, 2(10), 116, 118-121.
12. Tokunaga M., Larrow J.F., Kakiuchi F., Jacobsen E.N. Science 1997, 277:936-938.
13. Schaus S.E., Brandes B.D., Larrow J.F., et al. J. Am. Chem. Soc. 2002, 124(7):1307-1315.
14. Martinez L.E., Leighton J.L., Carsten D.H., Jacobsen E.N. J. Am. Chem. Soc. 1995, 117(21):5897-5898.
15. Leighton J.L., Jacobsen E.N. J. Org. Chem. 1996, 61(1):389-390.
16. Schaus S.E., Larrow J.F., Jacobsen E.N. J. Org. Chem. 1997, 62(12):4197-4199.
17. Jacobsen E.N., Kakiuchi F., Konsler R.G., Larrow J.F., Tokunaga M. Tetrahedron Lett. 1997, 38(5):773-776.
18. Larrow J.F., Schaus S.E., Jacobsen E.N. J. Am. Chem. Soc. 1996, 118(31):7420-7421.
19. Jacobsen E.N. Acc. Chem. Res. 2000, 33(6):421-431.
20. Ready J.M., Jacobsen E.N. J. Am. Chem. Soc. 1999, 121(25):6086-6087.
21. Hansen K.B., Leighton J.L., Jacobsen E.N. J. Am. Chem. Soc. 1996, 118(44):10924-10925.
22. Haak R.M., Wezenberg S.J., Kliej A.W. Chem. Commun. 2010, 46(16):2713-2723. For a recent review of cooperative catalysis by metallosalen complexes, see:.
23. Konsler R.G., Karl J., Jacobsen E.N. J. Am. Chem. Soc. 1998, 120(41):10780-10781.
24. Kemper S., Hrobárik P., Kaupp M., Schlörer N.E. J. Am. Chem. Soc. 2009, 131(12):4172-4173. For a solution-state study of several (salen)Co(III) complexes and potential implications to the conformation of 1b in the selectivity-determining step, see:.
25. Nielsen L.P.C., Stevenson C.P., Blackmond D.G., Jacobsen E.N. J. Am. Chem. Soc. 2004, 126(5):1360-1362. See also.
26. Jain S., Zheng X., Jones C.W., Weck M., Davis R.J. Inorg. Chem. 2007, 46(21):8887-8896.
27. Stevenson C.P., Nielsen L.P.C., Jacobsen E.N., et al. Org. Synth. 2006, 83:162-169. (Coll. Vol. 11, 2009, pp 157-163). See also a discussion in reference 2a (pp 132-134).
28. Nielson L.P.C., Zuend S.J., Ford D.D., Jacobsen E.N. J. Am. Chem. Soc. 2011, submitted for publication.
29. Bobb R., Alhakimi G., Studnicki L., Lough A., Chin J. J. Am. Chem. Soc. 2002, 124(17):4544-4545. For evidence of enantiomer discrimination through selective binding to chiral (salen)metal complexes, see:.
30. Fallis I.A., Murphy D.M., Willock D.J., et al. J. Am. Chem. Soc. 2004, 126(48):15660-15661.
31. Kim H.-J., Kim W., Lough A.J., Kim B.M., Chin J. J. Am. Chem. Soc. 2005, 127(48):16776-16777. See also refs. 15 and 16.
32. Aouni L., Hemberger K.E., Jasmin S., et al. Industrialization Studies of the Jacobsen Hydrolytic Kinetic Resolution of Epichlorohydrin. Asymmetric Catalysis on Industrial Scale 2004, 165-199. Wiley-VCH, Weinheim, Chapter II-2. H.-U. Blaser, E. Schmidt (Eds.).
33. Larrow, J. F.; Hemberger, K. E.; Kabir, H.; Morel, P. (Rhodia Pharma Solutions) Active Catalysts for Stereoselective Ring-Opening Reactions. US Patent 6,781,006, 2004.
34. Ready J.M., Jacobsen E.N. J. Am. Chem. Soc. 2001, 123(11):2687-2688.
35. Ready J.M., Jacobsen E.N. Angew. Chem. Int. Ed. 2002, 41(8):1374-1377.
36. White D.E., Jacobsen E.N. Tetrahedron: Asymmetry 2003, 14(22):3633-3638.
37. Anderson K.R., Atkinson S.L.G., Fujiwara T., et al. Org. Process Res. Dev. 2010, 14(1):58-71. For recent reports of other building blocks derived from PO, see:.
38. Wang H., Shuhler B.J., Xian M. J. Org. Chem. 2007, 72(11):4280-4283.
39. Rowley J.M., Lobkovsky E.B., Coates G.W. J. Am. Chem. Soc. 2007, 129(16):4948-4960.
40. Armilli, M. N.; Kundy, K. C.; Dougherty, J. P. et al. (Gilead Sciences, Inc.). Antiviral Phosphonomethoxy Nucleotide Analogs Having Increased Oral Bioavailability. US Patent 5,922,695, 1999.
41. Ripin D.H.B., Teager D.S., Fortunak J., et al. Org. Process Res. Dev. 2010, 14(5):1194-1201.
42. Bhide R.S., Cai Z.-W., Zhang Y.-Z., et al. J. Med. Chem. 2006, 49(7):2143-2146.
43. Takayanagi, Y.; Yokoyama, S. (Daiichi Seiyaku Co.). Method for Preparation of Optically Active [(nitrophenoxy)methyl]oxiranes. Japan. Patent JP2000302772.
44. Larrow, J. F. (Rhodia ChiRex, Inc.). Process for the Preparation of (R)-1-(aryloxy)propan-2-ol. US Patent 6,448,449, 2002.
45. Frater G., Mueller U., Kraft P. Helv. Chim. Acta 1999, 82(10):1656-1665.
46. Furrow M.E., Schaus S.E., Jacobsen E.N. J. Org. Chem. 1998, 63(20):6776-6777. Also see refs. 7 and 20.
47. Larrow J.F., Hemberger K.E., Jasmin S., Kabir H., Moral P. Tetrahedron: Asymmetry 2003, 14(22):3589-3592.
48. Larrow, J. F.; Jasmin, S.; Liu, Y.; DiMare, M. (Rhodia Pharma Solutions) Kinetic Resolution Method. US Patent 6,639,087, 2003.
49. This chiral building block has been primarily used to generate enantiopure 3-(aminomethyl)-morpholine derivatives useful as CCR-3 antagonists for the treatment of asthma. For example, see: Ancliff, R. A.; Cook, C. M.; Eldred, C. D.; et al. (Glaxo Group Ltd). Preparation of N-(morpholin-2-yl)methylacetamides as CCR-3 Antagonists Useful in the Treatment of Inflammatory Diseases. International Patent Appl. WO 2003082863 A1, 2003.
50. Ramalingam, K.; Raju, N. (Bracco International, B. V.). Heteroatom Bearing Ligands and Metal Complexes Thereof. US Patent 5,608,110, 1997.
51. Kim S.K., Jacobsen E.N. Angew. Chem. Int. Ed. 2004, 43(30):3952-3954. See also.
52. Bartoli G., Bosco M., Carlone A., et al. Org. Lett. 2004, 6(22):3973-3975.
53. Mattei P., Boehringer M., Di Giorgio P., et al. Bioorg. Med. Chem. Lett. 2010, 20(3):1109-1113.
54. Zutter, U. (F. Hoffmann-La Roche AG). Process for the Preparation of (S)-4-(fluoromethyl)dihydrofuran-2-one. US Patent Appl. 2008108816 A1, 2008.
55. Abrecht, S.; Adam, J.-M.; Fettes, A.; et al. (F. Hoffmann-La Roche AG). Preparation of (S)-4-fluoromethyl-dihydro-furan-2-one and its Use in Synthesis of Pyrido[2,1-a]isoquinoline Derivatives. International Patent Appl. WO 2006125728 A1, 2006.
56. Furukawa Y., Suzuki T., Mikami M., Kitaori K., Yoshimoto H. J. Synth. Org. Chem., Japan 2007, 65(4):308-319. For a review of access to many of these intermediates, see:.
57. Ok T., Jeon A., Lee J., et al. J. Org. Chem. 2007, 72(19):7390-7393.
58. See Brandes B.D., Jacobsen E.N. Tetrahedron: Asymmetry 1997, 8(23):3927-3933. and references therein.
59. BRITEST site. http://www.britest.co.uk.
60. Annis D.A., Jacobsen E.N. J. Am. Chem. Soc. 1999, 121(17):4147-4154. See also.
61. Zheng X., Jones C.W., Weck M. Adv. Synth. Catal. 2008, 350(2):255-261.
62. Breinbauer R., Jacobsen E.N. Angew. Chem. Int. Ed. 2000, 39(20):3604-3607.
63. Belser T., Jacobsen E.N. Adv. Synth. Catal. 2008, 350(7-8):967-971.
64. Zulauf A., Mellah M., Hong X., Schulz E. Dalton Transac. 2010, 39(30):6911-6935. For a recent review of this area, see:, and references therein. Also see ref. 13b.
65. Valera F.E., Quaranta M., Moran A., et al. Angew. Chem. Int. Ed. 2010, 49(14):2478-2485. For an interesting discussion of the benefits of continuous flow reactors relative to traditional batch chemistry, see:, and references therein.